Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5251 USD | -2.69% | +6.02% | +103.88% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.88% | 36.88M | |
+0.58% | 42.86B | |
+12.27% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+6.20% | 25.15B | |
-23.57% | 18.63B | |
+27.68% | 12.37B | |
-3.31% | 11.92B | |
+7.32% | 11.21B |
- Stock Market
- Equities
- BCLI Stock
- News Brainstorm Cell Therapeutics Inc.
- Maxim Group Adjusts Price Target on Brainstorm Cell Therapeutics to $10 From $5, Maintains Buy Rating